Qingsong Health surged 94% in HK grey market.

QingSong Health will use the IPO proceeds to increase its brand visibility and market position, as well as to enhance user engagement and deepen cooperation with business partners.
China International Capital Corporation, China Merchants Securities (HK), Futu Securities International (Hong Kong), and SPDB International Capital are the joint bookrunners of the IPO.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments